3i announces sale of OneMed generating proceeds of c. £100 million

By on Januar 29, 2019

3i Group plc (“3i”), and funds managed by 3i, have entered into a sale and purchase agreement to sell their investment in OneMed, the leading medical supplies distributor in Northern Europe, to Nalka Invest AB.

Proceeds to 3i will be c. £100m. The transaction is expected to complete in March 2019, subject to customary antitrust approvals.

3i invested in OneMed in 2011. During 3i’s ownership, the company successfully strengthened its market positions in Sweden, Denmark and Finland and built its international footprint through three strategic acquisitions in the Netherlands and a major expansion in Norway.

About 3i Group

3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com

About OneMed

OneMed is the leading medical supplies distributor in Northern Europe serving customers in the healthcare industry with reliable and efficient solutions for their entire need of supplies and related services. By adding a service offering (advanced decision support, healthcare procedure education, product range planning and streamlined ordering procedures) OneMed presents a comprehensive medical supplies solution where OneMed in collaboration with customers improves healthcare outcome, thus lowering total healthcare costs, improving the quality of care and creating a unique position in a non-cyclical subsector driven by structural growth themes.

This transaction involved a recommendation of 3i Investments plc, advised by 3i Benelux.

Mehr Informationen zu dieser und vielen anderen Transaktionen erhalten Sie HIER

Über 25.000 recherchierte Transaktionen seit 2005 - Legen Sie sich Ihre eigene Datenbank zu!

You must be logged in to post a comment Login